Mylocel and Sodium phosphate p 32 Intravenous
Determining the interaction of Mylocel and Sodium phosphate p 32 Intravenous and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using sodium phosphate p32 together with hydroxyurea may increase the risk of side effects that affect your bone marrow function, resulting in low numbers of different types of blood cells. You may be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should seek medical attention if you develop paleness, fatigue, dizziness, fainting, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The concomitant use of bone marrow depressants and sodium phosphate P-32 may have additive myelosuppressive effects.
MANAGEMENT: Patients should be monitored for excessive bone marrow suppression during treatment with sodium phosphate P-32. Dose reductions of the other bone marrow depressants may be necessary. Patients should be advised to contact their physician if they develop signs and symptoms of myelosuppression such as pallor, dizziness, fatigue, lethargy, fainting, easy bruising or bleeding, or signs of infection such as fever, chills, sore throat, body aches, and other influenza-like symptoms.
- AnazaoHealth Corporation "P32 Sodium Phosphate. Available from: URL: http://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=735f92e3-cc92-4d9b-afe8-f935a685ee78" ([2012 Jun]):
Generic Name: hydroxyurea
Brand name: Droxia, Hydrea, Mylocel, Siklos
Synonyms: n.a.
Generic Name: sodium phosphate p32
Brand name:
Synonyms: Sodium phosphate p 32 (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mylocel-Sodium Phosphates
- Mylocel-Sodium Phosphates Enema
- Mylocel-Sodium Phosphates Injection
- Mylocel-Sodium Phosphates Oral Solution
- Mylocel-Sodium Phosphates Tablets
- Mylocel-Sodium Picosulfate, Magnesium Oxide, and Citric Acid Powder for Solution
- Sodium phosphate p 32 Intravenous-Mylotarg
- Sodium phosphate p 32 Intravenous-Mylotarg Intravenous
- Sodium phosphate p 32 Intravenous-Mynephrocaps Dialysis Stress Vitamin Supplement
- Sodium phosphate p 32 Intravenous-Mynephron - 185
- Sodium phosphate p 32 Intravenous-Myobloc
- Sodium phosphate p 32 Intravenous-Myocard-DX